Caplin Point Laboratories Limited has informed the Exchange regarding Appointment of Mr Mr. Ashok Partheeban, Vivek Partheeban & K C John as Directors of the company w.e.f. November 05, 2025.
CAPLIPOINT · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Caplin Point Laboratories has appointed three new directors to its board — Mr. Ashok Partheeban, Mr. Vivek Partheeban, and K C John — with effect from November 5, 2025. Two of the appointees share the Partheeban surname, which is associated with the company's promoter family. K C John is a known promoter and key managerial figure at the company. The appointment appears to strengthen the promoter family's presence on the board along with an existing promoter.
The appointment increases promoter family representation on the board, which may reinforce continuity in the company's strategic direction but limits independent oversight. Shareholders should watch for related-party disclosures and governance practices going forward.